S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

SYRS Syros Pharmaceuticals Inc

0.1997

0.0147 (7.95%)

Feb 18 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Syros Pharmaceuticals Charts.

Syros Pharmaceuticals (NASDAQ:SYRS)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Syros Pharmaceuticals Charts.

Syros Pharmaceuticals Inc News

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (4 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 16 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 30 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 27 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 6 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 20 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 20 November 2024 (3 months ago) • Edgar (US Regulatory)

More Syros Pharmaceuticals Inc News Articles

TransCode Therapeutics

Digital Brand Media and ... (PK)

Clean Vision (QB)

TheGlobe com (PK)

Asia Broadband (PK)

AMC Entertainment

Bell Buckle (PK)

Intergrated Cannabis Sol... (PK)

Valiant Eagle (PK)

Super Micro Computer

Cann American (CE)

Rennova Health (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions